Get started
KOACT US CNS THERAPEUTICS ACTIVEKOACT US CNS THERAPEUTICS ACTIVEKOACT US CNS THERAPEUTICS ACTIVE

KOACT US CNS THERAPEUTICS ACTIVE

No trades
See on Supercharts
Overview
Analysis
Holdings Discussions Technicals Seasonals

Key stats


Assets under management (AUM)
‪5.90 B‬ KRW
Fund flows (1Y)
‪−2.88 B‬ KRW
Dividend yield (indicated)
—
Discount/Premium to NAV
0.7%
Shares outstanding
‪700.00 K‬
Expense ratio
0.50%

About KOACT US CNS THERAPEUTICS ACTIVE


Issuer
SAMSUNG LIFE INSURANCE
Brand
KoAct
Home page
samsungactive.co.kr
Inception date
Sep 3, 2024
Management style
Active
Primary advisor
Samsung Active Asset Management Co., Ltd.
ISIN
KR7490330008
The fund is actively managed ETF that seeks to outperform the daily performance of Solactive US CNS Therapeutics index by mainly investing in U.S. listed companies related to CNS Therapeutics.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Health care equipment & services
Strategy
Active
Geography
U.S.
Weighting scheme
Proprietary
Selection criteria
Proprietary

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance——————
NAV total return——————

What's in the fund


As of May 15, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks98.78%
Health Technology98.78%
Bonds, Cash & Other1.22%
Cash1.22%
Stock breakdown by region
83%16%
North America83.52%
Europe16.48%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows